Praluzatamab Biosimilar Anti-CD166 Antibody (DATK166)The Praluzatamab Biosimilar Anti-CD166 Antibody (DATK166) is a cutting-edge tool for researchers interested in studying CD166, a cell surface protein involved in cell adhesion and signaling processes. This monoclonal antibody, developed through advanced biosimilar technologies, is highly specific and sensitive for detecting CD166 in human samples. It has been rigorously validated for use in various applications, including immunohistochemistry and flow cytometry.CD166, also known as activated leukocyte cell adhesion molecule (ALCAM), plays a crucial role in cell migration, proliferation, and differentiation, making it a key player in cancer progression and metastasis.
Targeting CD166 with Praluzatamab can provide insights into the biology of tumors expressing this protein, aiding in the development of novel therapeutic strategies for cancer treatment.By offering a high level of specificity and sensitivity, the Praluzatamab Biosimilar Anti-CD166 Antibody (DATK166) is an invaluable tool for researchers studying cancer biology, tumor immunology, and drug development. Its ability to accurately detect and analyze CD166 expression in various cell types makes it a versatile and reliable choice for advancing scientific discoveries in the field of oncology.
Product Name:
Praluzatamab (Anti-CD166) Biosimilar Antibody
Size:
100 ug
Product SKU:
HDBS0154
Target:
CD166
Host Species:
Humanized
Reactivity:
Human
Recommended Dilution:
Flow Cyt 1:100
Antibody Type:
Monoclonal
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
CX-191
Description:
Anti-CD166(praluzatamab biosimilar) mAb
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
Flow Cyt
Antibody Isotype:
IgG1
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
